Transaction in Own Shares

Summary by AI ^BETAClose X

SThree plc has announced the purchase of 419,392 of its ordinary shares between May 28, 2026, and June 3, 2026, through Investec Bank plc. The volume-weighted average price for these purchases ranged from 165.4821 pence to 169.0467 pence per share, with the lowest price paid being 163.8000 pence and the highest 172.0000 pence. The company intends to cancel these repurchased shares.

Disclaimer*

SThree plc

05 June 2026

5^th June 2026

SThree plc

("SThree" or the "Company")

Transaction in Own Shares

The Company announces today it has purchased the following number of its ordinary shares of 1 pence each ("Ordinary Shares") through Investec Bank plc in the period from 28th May 2026 to 3rd June 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
28 May 2026	XLON	167.9028	96,228	165.6000	169.0000
29 May 2026	XLON	167.9496	40,757	164.2000	171.6000
01 June 2026	XLON	168.3506	86,484	167.2000	172.0000
02 June 2026	XLON	169.0467	95,559	166.6000	171.2000
03 June 2026	XLON	165.4821	110,368	163.8000	167.6000

The Company intends to cancel the purchased shares.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the Investec Bank on behalf of the Company as part of the buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/0189H_1-2026-6-4.pdf

For further information please contact:

SThree plc
Timo Lehne, CEO Damian Fehrenberg, Interim CFO Charlie Hildesley, Investor Relations Manager	via Alma
Alma Strategic Communications	+44 20 3405 0205
Rebecca Sanders-Hewett Hilary Buchanan Sam Modlin Rose Docherty	SThree@almastrategic.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END